Economic and feasibility comparison of the dRIT and DFA for decentralized rabies diagnosis in resource-limited settings: The use of Nigerian dog meat markets as a case study.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
02 2020
Historique:
received: 20 02 2019
accepted: 26 01 2020
revised: 11 03 2020
pubmed: 29 2 2020
medline: 28 4 2020
entrez: 29 2 2020
Statut: epublish

Résumé

Rabies lyssavirus (RABV) is the aetiologic agent of rabies, a disease that is severely underreported in Nigeria as well as elsewhere in Africa and Asia. Despite the role that rabies diagnosis plays towards elucidating the true burden of the disease, Nigeria-a country of 180 million inhabitants-has a limited number of diagnostic facilities. In this study, we sought to investigate two of the World Organization for Animal Health (OIE)-recommended diagnostic assays for rabies-viz; the direct fluorescent antibody test (DFA) and the direct rapid immunohistochemical test (dRIT) in terms of their relative suitability in resource-limited settings. Our primary considerations were (1) the financial feasibility for implementation and (2) the diagnostic efficacy. As a case study, we used suspect rabies samples from dog meat markets in Nigeria. By developing a simple simulation framework, we suggested that the assay with the lowest cost to implement and routinely use was the dRIT assay. The costs associated with the dRIT were lower in all simulated scenarios, irrespective of the number of samples tested per year. In addition to the cost analysis, the diagnostic efficacies of the two assays were evaluated. To do this, a cohort of DFA-positive and -negative samples collected from dog meat markets in Nigeria were initially diagnosed using the DFA in Nigeria and subsequently sent to South Africa for diagnostic confirmation. In South Africa, all the specimens were re-tested with the DFA, the dRIT and a quantitative real-time polymerase chain reaction (qRT-PCR). In our investigation, discrepancies were observed between the three diagnostic assays; with the incongruent results being resolved by means of confirmatory testing using the heminested reverse transcription polymerase reaction and sequencing to confirm that they were not contamination. The data obtained from this study suggested that the dRIT was not only an effective diagnostic assay that could be used to routinely diagnose rabies, but that the assay was also the most cost-effective option among all of the OIE recommended methods. In addition, the results of our investigation confirmed that some of the dogs slaughtered in dog markets were rabies-positive and that the markets posed a potential public health threat. Lastly, our data showed that the DFA, although regarded as the gold standard test for rabies, has some limitations-particularly at low antigen levels. Based on the results reported here and the current challenges faced in Nigeria, we believe that the dRIT assay would be the most suitable laboratory test for decentralized or confirmatory rabies diagnosis in Nigeria, given its relative speed, accuracy, cost and ease of use.

Sections du résumé

BACKGROUND
Rabies lyssavirus (RABV) is the aetiologic agent of rabies, a disease that is severely underreported in Nigeria as well as elsewhere in Africa and Asia. Despite the role that rabies diagnosis plays towards elucidating the true burden of the disease, Nigeria-a country of 180 million inhabitants-has a limited number of diagnostic facilities. In this study, we sought to investigate two of the World Organization for Animal Health (OIE)-recommended diagnostic assays for rabies-viz; the direct fluorescent antibody test (DFA) and the direct rapid immunohistochemical test (dRIT) in terms of their relative suitability in resource-limited settings. Our primary considerations were (1) the financial feasibility for implementation and (2) the diagnostic efficacy. As a case study, we used suspect rabies samples from dog meat markets in Nigeria.
METHODS/PRINCIPAL FINDINGS
By developing a simple simulation framework, we suggested that the assay with the lowest cost to implement and routinely use was the dRIT assay. The costs associated with the dRIT were lower in all simulated scenarios, irrespective of the number of samples tested per year. In addition to the cost analysis, the diagnostic efficacies of the two assays were evaluated. To do this, a cohort of DFA-positive and -negative samples collected from dog meat markets in Nigeria were initially diagnosed using the DFA in Nigeria and subsequently sent to South Africa for diagnostic confirmation. In South Africa, all the specimens were re-tested with the DFA, the dRIT and a quantitative real-time polymerase chain reaction (qRT-PCR). In our investigation, discrepancies were observed between the three diagnostic assays; with the incongruent results being resolved by means of confirmatory testing using the heminested reverse transcription polymerase reaction and sequencing to confirm that they were not contamination.
CONCLUSIONS/SIGNIFICANCE
The data obtained from this study suggested that the dRIT was not only an effective diagnostic assay that could be used to routinely diagnose rabies, but that the assay was also the most cost-effective option among all of the OIE recommended methods. In addition, the results of our investigation confirmed that some of the dogs slaughtered in dog markets were rabies-positive and that the markets posed a potential public health threat. Lastly, our data showed that the DFA, although regarded as the gold standard test for rabies, has some limitations-particularly at low antigen levels. Based on the results reported here and the current challenges faced in Nigeria, we believe that the dRIT assay would be the most suitable laboratory test for decentralized or confirmatory rabies diagnosis in Nigeria, given its relative speed, accuracy, cost and ease of use.

Identifiants

pubmed: 32109246
doi: 10.1371/journal.pntd.0008088
pii: PNTD-D-19-00264
pmc: PMC7065817
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008088

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exist

Références

PLoS Negl Trop Dis. 2008 Mar 26;2(3):e206
pubmed: 18365035
Arch Virol. 2019 Apr;164(4):1233-1244
pubmed: 30663023
US Army Med Dep J. 2009 Jan-Mar;:42-5
pubmed: 20088045
Emerg Infect Dis. 2006 Dec;12(12):1913-8
pubmed: 17326944
PLoS Negl Trop Dis. 2017 Apr 3;11(4):e0005427
pubmed: 28369139
Glob J Health Sci. 2013 Oct 27;6(1):107-14
pubmed: 24373270
Glob J Health Sci. 2013 Nov 03;6(1):142-53
pubmed: 24373274
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2008 Jun;22(3):168-70
pubmed: 19031692
PLoS Negl Trop Dis. 2014 Sep 25;8(9):e3189
pubmed: 25254652
Emerg Infect Dis. 2006 Feb;12(2):310-3
pubmed: 16494761
J Clin Microbiol. 1997 Nov;35(11):2762-6
pubmed: 9350729
J Clin Microbiol. 2010 Nov;48(11):3949-55
pubmed: 20810772
Niger Postgrad Med J. 2006 Jun;13(2):128-34
pubmed: 16794650
J S Afr Vet Assoc. 2017 Mar 24;88(0):e1-e9
pubmed: 28397511
J Virol Methods. 2013 Jul;191(1):88-94
pubmed: 23578701
ISRN Vet Sci. 2013 Dec 12;2013:468043
pubmed: 24416598
PLoS Negl Trop Dis. 2010 Nov 30;4(11):e839
pubmed: 21152052
Animals (Basel). 2011 Sep 26;1(4):326-42
pubmed: 26486619
PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709
pubmed: 25881058
Ann Indian Acad Neurol. 2008 Jan;11(1):3-12
pubmed: 19966972
Mol Biol Evol. 2007 Aug;24(8):1596-9
pubmed: 17488738
Antiviral Res. 2013 Jun;98(3):357-64
pubmed: 23603498
Virol Sin. 2012 Oct;27(5):299-302
pubmed: 23055005
Vet Sci. 2018 Feb 28;5(1):
pubmed: 29495649
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904

Auteurs

Eze U Ukamaka (EU)

Department of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.

Andre Coetzer (A)

Department of Biochemistry, Genetics and Microbiology,University of Pretoria, Pretoria, South Africa.
Global Alliance for Rabies Control SA NPC, Pretoria, South Africa.

Terence P Scott (TP)

Department of Biochemistry, Genetics and Microbiology,University of Pretoria, Pretoria, South Africa.
Global Alliance for Rabies Control SA NPC, Pretoria, South Africa.

Boniface M Anene (BM)

Department of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.

Romanus C Ezeokonkwo (RC)

Department of Veterinary Parasitology and Entomology, Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.

Chika I Nwosuh (CI)

Rabies Unit, Central Diagnostic Laboratory, National Veterinary Research Institute, Vom, Jos, Nigeria.

Louis H Nel (LH)

Department of Biochemistry, Genetics and Microbiology,University of Pretoria, Pretoria, South Africa.
Global Alliance for Rabies Control SA NPC, Pretoria, South Africa.

Claude T Sabeta (CT)

OIE Rabies Reference Laboratory, Agricultural Research Council-Onderstepoort Veterinary Institute, Pretoria, South Africa.
Department of Veterinary Tropical Diseases, University of Pretoria, Pretoria, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH